Princeton Alpha Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Princeton Alpha Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-20,541	Closed	-$107K	–	321
2017 Q1	$107K	Sell	20,541 -15,585	-43%	-$62.5K	0.04%	513
2016 Q4	$110K	Buy	36,126 +14,885	+70%	+$54.2K	0.02%	650
2016 Q3	$98K	Sell	21,241 -7,087	-25%	-$36K	0.02%	707
2016 Q2	$164K	Buy	+28,328	New	+$181K	0.03%	692
2016 Q1	–	Sell	-16,895	Closed	-$154K	–	897
2015 Q4	$154K	Buy	+16,895	New	+$130K	0.03%	665
2015 Q3	–	Sell	-12,850	Closed	-$143K	–	881
2015 Q2	$143K	Buy	+12,850	New	+$166K	0.03%	638
2015 Q1	–	Sell	-10,809	Closed	-$164K	–	868
2014 Q4	$164K	Buy	+10,809	New	+$131K	0.05%	599

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Princeton Alpha Management's SGMO Position: Q2 2017 in Review

Princeton Alpha Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2017, closing a stake of 20,541 shares — an estimated $107K sold.

Princeton Alpha Management first reported a position in SGMO in Q4 2014 and held it in 7 quarters. The position peaked at $164K in Q2 2016. 143 funds tracked by Wall St. Rank hold SGMO as of Q2 2017.

Princeton Alpha Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 20,541 SANGAMO THERAPEUTICS INC shares in Q2 2017, an estimated $107K.
Princeton Alpha Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 7 quarters.
Princeton Alpha Management's SANGAMO THERAPEUTICS INC position peaked at $164K in Q2 2016.
143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.